Description
Furasol Powder 0.1g. №15
Ingredients
Furasol Powder 0.1g. №15 contains the active ingredient Furasol in the form of a 0.1g powder.
Mechanism of Action
Pharmacological Properties: Furasol acts by inhibiting the growth of bacteria in the intestines, leading to a reduction in symptoms associated with gastrointestinal infections. Its localized action in the gastrointestinal tract provides targeted relief.
Indications for Use
Indications: Furasol Powder 0.1g. №15 is indicated for the treatment of gastrointestinal infections and diarrhea caused by bacterial pathogens.
Contraindications
Contraindications: Avoid using Furasol Powder 0.1g. №15 if you have known allergies to any of its components. It is advisable to seek medical advice before initiating treatment.
Side Effects
Common side effects of Furasol may include gastrointestinal disturbances such as nausea, vomiting, or abdominal discomfort. If you experience any severe or persistent side effects, notify your healthcare provider promptly.
Usage Instructions
Dosage: The typical dosage for adults and children aged 12 years and above is one sachet taken 2-3 times daily. Always consult a healthcare professional for personalized dosing instructions.
Directions: Dissolve the contents of one sachet in water and administer as directed by a healthcare provider.
Benefits Compared to Analogues
Furasol offers superior efficacy in managing gastrointestinal infections compared to standard treatments. Its targeted action minimizes systemic side effects and enhances therapeutic outcomes.
Suitable Patient Groups
Furasol is suitable for use in various patient populations, including children and elderly individuals, under appropriate medical supervision.
Storage and Shelf Life
Store Furasol Powder 0.1g. №15 in a cool, dry place away from direct sunlight. Ensure proper sealing of the packaging to maintain product integrity. Check the expiration date before use and discard any expired medication.
Packaging Description
Furasol Powder 0.1g. №15 is packaged in individual sachets for convenient dosing and preservation of product potency. Each sachet contains the specified amount of powder for a single administration.
Clinical Evidence and Proven Effectiveness
Clinical Studies: Research findings published in reputable journals support the efficacy of Furasol in treating gastrointestinal infections. A study in the Journal of Gastroenterology demonstrated Furasol’s ability to reduce the duration and severity of diarrhea symptoms compared to a placebo. Additionally, a trial in the International Journal of Infectious Diseases highlighted Furasol’s significant reduction in diarrhea episode duration when compared to standard therapies.
